메뉴 건너뛰기




Volumn 36, Issue 6, 2008, Pages 1979-1981

Levo is in the air: Take a deep breath!

Author keywords

Acute lung injury; Hemodynamics; Levosimendan; Sepsis; Septic shock; Ventilator induced lung injury

Indexed keywords

ADRENERGIC RECEPTOR; ANTIBIOTIC AGENT; CATECHOLAMINE; DOBUTAMINE; HEMOGLOBIN; LEVOSIMENDAN; NORADRENALIN; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

EID: 45149111309     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318176aae9     Document Type: Editorial
Times cited : (2)

References (13)
  • 1
    • 33747456675 scopus 로고    scopus 로고
    • Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study
    • Morelli A, Teboul JL, Maggiore SM, et al: Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study. Crit Care Med 2006; 34:2287-2293
    • (2006) Crit Care Med , vol.34 , pp. 2287-2293
    • Morelli, A.1    Teboul, J.L.2    Maggiore, S.M.3
  • 2
    • 45149117353 scopus 로고    scopus 로고
    • Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury
    • Boost KA, Hoegl S, Hofstetter C, et al: Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury. Crit Care Med 2008; 36: 1873-1879
    • (2008) Crit Care Med , vol.36 , pp. 1873-1879
    • Boost, K.A.1    Hoegl, S.2    Hofstetter, C.3
  • 4
    • 0442329090 scopus 로고    scopus 로고
    • Ventilation-induced neutrophil infiltration depends on c-Jun N-terminal kinase
    • Li LF, Yu L, Quinn DA: Ventilation-induced neutrophil infiltration depends on c-Jun N-terminal kinase. Am J Respir Crit Care Med 2004; 169:518-524
    • (2004) Am J Respir Crit Care Med , vol.169 , pp. 518-524
    • Li, L.F.1    Yu, L.2    Quinn, D.A.3
  • 5
    • 0031734199 scopus 로고    scopus 로고
    • Endo-thelin-1 and thromboxane A2 increase pulmonary vascular resistance in granulocyte-mediated lung injury
    • Schmeck J, Janzen R, Munter K, et al: Endo-thelin-1 and thromboxane A2 increase pulmonary vascular resistance in granulocyte-mediated lung injury. Crit Care Med 1998; 26:1868-1874
    • (1998) Crit Care Med , vol.26 , pp. 1868-1874
    • Schmeck, J.1    Janzen, R.2    Munter, K.3
  • 6
    • 33646542726 scopus 로고    scopus 로고
    • Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury
    • Mendez MP, Morris SB, Wilcoxen S, et al: Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 290:L962-L970
    • (2006) Am J Physiol Lung Cell Mol Physiol , vol.290
    • Mendez, M.P.1    Morris, S.B.2    Wilcoxen, S.3
  • 7
    • 39649094117 scopus 로고    scopus 로고
    • Effects of levosimendan on flow-mediated va-sodilation and soluble adhesion molecules in patients with advanced chronic heart failure
    • Parissis JT, Karavidas A, Bistola V, et al: Effects of levosimendan on flow-mediated va-sodilation and soluble adhesion molecules in patients with advanced chronic heart failure. Atherosclerosis 2008;197:278-282
    • (2008) Atherosclerosis , vol.197 , pp. 278-282
    • Parissis, J.T.1    Karavidas, A.2    Bistola, V.3
  • 8
    • 0031958567 scopus 로고    scopus 로고
    • Coronary vasorelaxant effect of levosi-mendan, a new inodilator with calcium-sensitizing properties
    • Gruhn N, Nielsen-Kudsk JE, Theilgaard S, et al: Coronary vasorelaxant effect of levosi-mendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol 1998; 31:741-749
    • (1998) J Cardiovasc Pharmacol , vol.31 , pp. 741-749
    • Gruhn, N.1    Nielsen-Kudsk, J.E.2    Theilgaard, S.3
  • 9
    • 85133377009 scopus 로고    scopus 로고
    • Zager RA, Johnson AC, Lund S, et al: Levo-simendan protects against experimental en-dotoxemic acute renal failure. Am J Physiol Renal Physiol 2006; 290:F1453-F1462 10. Lepran I, Pollesello P, Vajda S, et al: Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model. J Cardiovasc Pharmacol 2006; 48:148-152
    • Zager RA, Johnson AC, Lund S, et al: Levo-simendan protects against experimental en-dotoxemic acute renal failure. Am J Physiol Renal Physiol 2006; 290:F1453-F1462 10. Lepran I, Pollesello P, Vajda S, et al: Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model. J Cardiovasc Pharmacol 2006; 48:148-152
  • 10
    • 33745168603 scopus 로고    scopus 로고
    • Effects of levosimendan versus dobutamine on inflammatory and apopto-tic pathways in acutely decompensated chronic heart failure
    • Adamopoulos S, Parissis JT, Iliodromitis EK, et al: Effects of levosimendan versus dobutamine on inflammatory and apopto-tic pathways in acutely decompensated chronic heart failure. Am J Cardiol 2006; 98:102-106
    • (2006) Am J Cardiol , vol.98 , pp. 102-106
    • Adamopoulos, S.1    Parissis, J.T.2    Iliodromitis, E.K.3
  • 11
    • 0035829842 scopus 로고    scopus 로고
    • Early goal-directed therapy in the treatment of severe sepsis and septic shock
    • Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Medt 2001; 345:1368-1377
    • (2001) N Engl J Medt , vol.345 , pp. 1368-1377
    • Rivers, E.1    Nguyen, B.2    Havstad, S.3
  • 12
    • 34250856943 scopus 로고    scopus 로고
    • Continuous terlipressin infusion in patients with septic shock: Less may be best, and the earlier the better?
    • Morelli A, Ertmer C, Lange M, et al: Continuous terlipressin infusion in patients with septic shock: Less may be best, and the earlier the better? Intensive Care Med 2007; 33:1669-1670
    • (2007) Intensive Care Med , vol.33 , pp. 1669-1670
    • Morelli, A.1    Ertmer, C.2    Lange, M.3
  • 13
    • 33744527833 scopus 로고    scopus 로고
    • Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
    • Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596
    • (2006) Crit Care Med , vol.34 , pp. 1589-1596
    • Kumar, A.1    Roberts, D.2    Wood, K.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.